Literature DB >> 29186428

Genome-wide meta-analysis identifies novel determinants of circulating serum progranulin.

Anke Tönjes1, Markus Scholz2,3, Jacqueline Krüger4, Kerstin Krause1, Dorit Schleinitz1, Holger Kirsten2,3, Claudia Gebhardt1, Carola Marzi5,6,7, Harald Grallert5,6,7, Claes Ladenvall8, Henrike Heyne9, Esa Laurila8, Jennifer Kriebel5,6,7, Christa Meisinger6,7, Wolfgang Rathmann10, Christian Gieger5,6, Leif Groop8, Inga Prokopenko11,12,13, Bo Isomaa14,15, Frank Beutner16, Jürgen Kratzsch16, Antje Fischer-Rosinsky17, Andreas Pfeiffer17,18, Knut Krohn19, Joachim Spranger17, Joachim Thiery16, Matthias Blüher1,4, Michael Stumvoll1,4, Peter Kovacs4.   

Abstract

Progranulin is a secreted protein with important functions in processes including immune and inflammatory response, metabolism and embryonic development. The present study aimed at identification of genetic factors determining progranulin concentrations. We conducted a genome-wide association meta-analysis for serum progranulin in three independent cohorts from Europe: Sorbs (N = 848) and KORA (N = 1628) from Germany and PPP-Botnia (N = 335) from Finland (total N = 2811). Single nucleotide polymorphisms (SNPs) associated with progranulin levels were replicated in two additional German cohorts: LIFE-Heart Study (Leipzig; N = 967) and Metabolic Syndrome Berlin Potsdam (Berlin cohort; N = 833). We measured mRNA expression of genes in peripheral blood mononuclear cells (PBMC) by micro-arrays and performed mRNA expression quantitative trait and expression-progranulin association studies to functionally substantiate identified loci. Finally, we conducted siRNA silencing experiments in vitro to validate potential candidate genes within the associated loci. Heritability of circulating progranulin levels was estimated at 31.8% and 26.1% in the Sorbs and LIFE-Heart cohort, respectively. SNPs at three loci reached study-wide significance (rs660240 in CELSR2-PSRC1-MYBPHL-SORT1, rs4747197 in CDH23-PSAP and rs5848 in GRN) explaining 19.4%/15.0% of the variance and 61%/57% of total heritability in the Sorbs/LIFE-Heart Study. The strongest evidence for association was at rs660240 (P = 5.75 × 10-50), which was also associated with mRNA expression of PSRC1 in PBMC (P = 1.51 × 10-21). Psrc1 knockdown in murine preadipocytes led to a consecutive 30% reduction in progranulin secretion. In conclusion, the present meta-GWAS combined with mRNA expression identified three loci associated with progranulin and supports the role of PSRC1 in the regulation of progranulin secretion.
© The Author(s) 2017. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29186428     DOI: 10.1093/hmg/ddx413

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  6 in total

1.  Deficiency of PSRC1 accelerates atherosclerosis by increasing TMAO production via manipulating gut microbiota and flavin monooxygenase 3.

Authors:  Tiantian Luo; Zhigang Guo; Dan Liu; Zhongzhou Guo; Qiao Wu; Qinxian Li; Rongzhan Lin; Peier Chen; Caiwen Ou; Minsheng Chen
Journal:  Gut Microbes       Date:  2022 Jan-Dec

2.  Probing the Virtual Proteome to Identify Novel Disease Biomarkers.

Authors:  Jonathan D Mosley; Mark D Benson; J Gustav Smith; Olle Melander; Debby Ngo; Christian M Shaffer; Jane F Ferguson; Matthew S Herzig; Catherine A McCarty; Christopher G Chute; Gail P Jarvik; Adam S Gordon; Melody R Palmer; David R Crosslin; Eric B Larson; David S Carrell; Iftikhar J Kullo; Jennifer A Pacheco; Peggy L Peissig; Murray H Brilliant; Terrie E Kitchner; James G Linneman; Bahram Namjou; Marc S Williams; Marylyn D Ritchie; Kenneth M Borthwick; Krzysztof Kiryluk; Frank D Mentch; Patrick M Sleiman; Elizabeth W Karlson; Shefali S Verma; Yineng Zhu; Ramachandran S Vasan; Qiong Yang; Josh C Denny; Dan M Roden; Robert E Gerszten; Thomas J Wang
Journal:  Circulation       Date:  2018-11-27       Impact factor: 29.690

3.  Genetically programmed changes in transcription of the novel progranulin regulator.

Authors:  Maria Keller; Claudia Gebhardt; Sandra Huth; Dorit Schleinitz; Henrike Heyne; Markus Scholz; Michael Stumvoll; Yvonne Böttcher; Anke Tönjes; Peter Kovacs
Journal:  J Mol Med (Berl)       Date:  2020-07-03       Impact factor: 4.599

4.  Anti-sortilin1 Antibody Up-Regulates Progranulin via Sortilin1 Down-Regulation.

Authors:  Shuuichi Miyakawa; Hiroyuki Sakuma; Dnyaneshwar Warude; Satomi Asanuma; Naoto Arimura; Tomoki Yoshihara; Daniel Tavares; Akito Hata; Koh Ida; Yuri Hori; Yuumi Okuzono; Syunsuke Yamamoto; Koichi Iida; Hisao Shimizu; Shinichi Kondo; Shuji Sato
Journal:  Front Neurosci       Date:  2020-12-15       Impact factor: 4.677

5.  Serum progranulin is not associated with rs5848 polymorphism in Korean patients with neurodegenerative diseases.

Authors:  Na-Yeon Jung; Hyang-Sook Kim; Eun Soo Kim; Sumin Jeon; Myung Jun Lee; Kyoungjune Pak; Jae-Hyeok Lee; Young Min Lee; Kangyoon Lee; Jin-Hong Shin; Jun Kyeung Ko; Jae Meen Lee; Jin A Yoon; Chungsu Hwang; Kyung-Un Choi; Gi Yeong Huh; Young-Eun Kim; Eun-Joo Kim
Journal:  PLoS One       Date:  2022-01-27       Impact factor: 3.240

6.  The FAM171A2 gene is a key regulator of progranulin expression and modifies the risk of multiple neurodegenerative diseases.

Authors:  Wei Xu; Si-Da Han; Can Zhang; Jie-Qiong Li; Yan-Jiang Wang; Chen-Chen Tan; Hong-Qi Li; Qiang Dong; Cui Mei; Lan Tan; Jin-Tai Yu
Journal:  Sci Adv       Date:  2020-10-21       Impact factor: 14.957

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.